Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 82

Life Science Drug Development Digital Health Health IT 82

Healthcare IT News - Telehealth

JANUARY 20, 2022

Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. You predict that decentralization will become a major theme for health and life science organizations. Please elaborate.

Life Science 178

Life Science Primary Care Mental health Drug Development 178

Society for Participatory Medicine

JANUARY 27, 2022

The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care. Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users.

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” For more information, please visit www.avilar-tx.com and follow us on Twitter @Avilar_Tx and on LinkedIn.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Its mission is to improve patient outcomes, train the next generation of scientists and clinicians, and enhance the competitiveness of the UK life sciences sector.

Life Science 88

Life Science BioTech Drug Development Health science 88

Digital Health Global

NOVEMBER 20, 2023

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. However, they are vital to the drug development and approval process and critical in enabling access to innovative medicines.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals 64

Pharmaceuticals Digital Health Drug Development Life Science 64

Healthcare IT Today

NOVEMBER 14, 2022

Brad Whitmore is a successful investor who has targeted a broad range of investments across various industries with an emphasis on businesses with long-term, sustainable competitive advantages and unique offerings relative to competitors. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95

Healthcare IT Today

JULY 25, 2022

Cornerstone’s founders incubated the company in partnership with Initiate Studios, a new venture studio that co-creates companies at the intersection of healthcare, life sciences and technology. AI/ML is revolutionizing the healthcare industry,” said Schiess. Learn more at www.healthy.vc.

Life Science 80

Life Science Drug Development Digital Health Health Data 80

Healthcare IT Today

JANUARY 23, 2024

By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. QuantHealth is already working with several global pharmaceutical companies to use its product in clinical trial design and development. Petra Jantzer, Ph.D., Petra Jantzer, Ph.D.,

Drug Development 88

Drug Development Pharmaceuticals Life Science BioTech 88

Healthcare IT Today

APRIL 25, 2024

Mati Gil, CEO at AION Labs , stands at the forefront of this revolution, pioneering the use of AI to tackle the challenges inherent in the pharma industry. In a recent video interview below, he shared insights into how AI is transforming drug discovery, emphasizing the need for innovation in an industry marked by complexity and high stakes.

Pharmaceuticals 114

Pharmaceuticals Drug Development BioTech Life Science 114

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 167

Drug Development Pharmaceuticals Life Science Digital Health 167

Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. It has been used in various studies in Europe with great results.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. Contacts Isabella Morreale quanthealth@solcomms.co

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Henry Kotula

MARCH 10, 2021

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

Life Science 41

Life Science Pharmaceuticals Drug Development EHR 41

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

The Digital Health Corner

MARCH 26, 2018

Blockchain technology’s potential impact on the life sciences industry (drug development, distribution and prescribing) is significant. It can impact the opioid crisis and improve tracking drugs in the supply chain.

Digital Health 117

Digital Health Interoperability Life Science Healthcare Data Security 117

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. One of the core issues is that the industry has become single threaded in its sourcing strategy. Check out our community’s pharma predictions.

Health IT 86

Health IT Pharmaceuticals Drug Development Life Science 86

Healthcare IT Today

JANUARY 17, 2024

Greg Wujek, Global Health Industry Consultant at SAS Robots as providers comes of age. The use of robots in health care will exponentially mature with the development of robots capable of performing basic medical tasks, such as taking vital signs, administering medications, and providing wound care.

Health IT 104

Health IT Mental health Interoperability Patient Experience 104